Acute coagulopathy and inflammation of trauma-3

Acute coagulopathy and inflammation of trauma-3 - ACIT trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42991

Enrollment

500

Registered

2016-11-23

Start date

2016-12-02

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

clotting disorder coagulopathy

Interventions

coagulopathy

inflammation

transfusion

trauma

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Age > 18 years Sustained a blunt or penetrating trauma, with at least one of the following clinical parameters: o Reparatory rate 25 times per minute o Heart rate *120 per minute o Systolic blood pressure

Exclusion criteria

Exclusion criteria: Age 5% of their body surface area Patients taking anticoagulant medication other than aspirin (

Design outcomes

Primary

Measure	Time frame
28 day mortality	—

Secondary

Measure	Time frame
Blood transfusion requirement in first 24 hours, length of hospital stay, ICU stay, 28-day ventilator free days, occurrence of acute lung injury (ALI), acute respiratory distress syndrome (ARDS), acute kidney injury (AKI) and multiple organ failure (MOF)	—

Countries

Denmark, Germany, Netherlands, Norway, United Kingdom

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)